3
Announcements
Trials
Browse
Landscape
Status
Completed
3
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Neoplasms
10
Prostatic Neoplasms
8
Head and Neck Neoplasms
8
Colorectal Neoplasms
8
Breast Neoplasms
7
Motor Activity
6
Ovarian Neoplasms
5
Rectal Neoplasms
4
Oropharyngeal Neoplasms
4
Multiple Myeloma
4
Endometrial Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Mouth Neoplasms
3
Hematologic Neoplasms
3
Colorectal Neoplasms, Hereditary Nonpolyposis
3
COVID-19
3
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Pancreatic Neoplasms
2
Obesity
2
Nasopharyngeal Neoplasms
2
Lymphoma
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia
2
Leiomyoma
2
Laryngeal Neoplasms
2
Hypopharyngeal Neoplasms
2
Hematological Cancer
2
Colonic Neoplasms
2
Carcinoma, Squamous Cell
2
Interventions
Ipilimumab
3
Triamcinolone Acetonide
2
Ranibizumab
2
Nivolumab
2
Amplified Fragment Length Polymorphism Analysis
2
treosulfan
1
salicylhydroxamic acid
1
aldesleukin
1
Ultrasonography
1
Tramadol
1
Temozolomide
1
Tamoxifen
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Sunitinib
1
Sorafenib
1
Rose Bengal
1
Radiosurgery
1
Physical Examination
1
Pharmacogenomic Testing
1
Interviews as Topic
1
Immunotherapy
1
Ibuprofen
1
Gemcitabine
1
Eye Enucleation
1
Cyclophosphamide
1
Cisplatin
1
Chemotherapy, Adjuvant
1
CTLA-4 Antigen
1
Brachytherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Uveal Melanoma
×
Surveys and Questionnaires
×
Clear all
NCT06073548
2023-10-10
SALOME Quali
Institut Curie
Unknown
250 enrolled